<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Sensitivity analysis in an Immuno-Epidemiological Vector-Host Model - Health AI Hub</title>
    <meta name="description" content="This paper introduces a novel approach to Sensitivity Analysis (SA) by integrating within-host virus-immune system interactions with population-level epidemic m">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Sensitivity analysis in an Immuno-Epidemiological Vector-Host Model</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2111.11386v1" target="_blank">2111.11386v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2021-11-22
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Hayriye Gulbudak, Zhuolin Qu, Fabio Milner, Necibe Tuncer
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> q-bio.PE, q-bio.QM
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.90 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2111.11386v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="None" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces a novel approach to Sensitivity Analysis (SA) by integrating within-host virus-immune system interactions with population-level epidemic models. It utilizes an age-since-infection structured vector-host model where epidemiological parameters are functions of within-host dynamics, demonstrating that immunological parameters significantly impact population-scale disease metrics like R0 and infectiousness, with a case study on Rift Valley Fever Disease.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research bridges the gap between micro-scale immunological processes and macro-scale epidemic dynamics, providing a more comprehensive understanding of disease spread that can directly inform the development of drugs, vaccines, and public health interventions by identifying crucial within-host targets.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The paper utilizes mathematical modeling (ODE systems) and Sensitivity Analysis, which are computational methods in health research. While these methods can complement AI approaches, the paper itself does not describe or apply specific AI technologies (e.g., machine learning, deep learning) as its primary method or application in a healthcare context.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Traditional Sensitivity Analysis (SA) in epidemic models often neglects within-host virus-immune system interactions, which this study addresses by creating an immuno-epidemiological framework.</li>
                    
                    <li>The research connects individual-level (within-host) viral and antibody dynamics, governed by an ODE system, to population-level disease spread in an age-since-infection structured vector-host model.</li>
                    
                    <li>Immunological parameters are shown to significantly influence population-level quantities such as the basic reproduction number (R0), final epidemic size, and host infectiousness at different outbreak phases.</li>
                    
                    <li>As a case study, Rift Valley Fever Disease (RFVD) was modeled, using established parameter estimations.</li>
                    
                    <li>Quantitative results indicate that a 1% increase in within-host pathogen growth rate can lead to an 8% increase in R0, a 1% increase in steady-state infected host abundance, and a 4% increase in host infectiousness when R0 > 1.</li>
                    
                    <li>The findings emphasize that targeting within-host pathogen growth, potentially through antiviral therapies or immune modulators, could be a critical strategy for reducing population-level disease prevalence.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study employs Sensitivity Analysis (SA) on an age-since-infection structured vector-host model. This model integrates within-host virus and antibody dynamics, which are governed by an Ordinary Differential Equation (ODE) system, directly linking them to epidemiological parameters. The framework investigates the impact of immunological parameters on population-level disease quantities like R0, final epidemic size, and infectiousness. Rift Valley Fever Disease serves as a case study, utilizing existing parameter estimations.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>A 1% increase in the within-host pathogen growth rate can lead to an 8% increase in the basic reproduction number (R0), a 1% increase in steady-state infected host abundance, and a 4% increase in the infectiousness of hosts, particularly when R0 is greater than one. These effects are significant at the population scale.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>The findings suggest that control strategies focusing on reducing the within-host pathogen growth rate, for instance through specific antiviral medications or immune-boosting therapies, could be highly effective in mitigating population-level disease prevalence. This can guide the design of more targeted drug and vaccine development efforts by identifying critical immunological pathways influencing disease spread.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state any limitations of the study. It focuses on the novelty and findings of the proposed model.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The abstract does not explicitly state future research directions. However, the implication is further application of this immuno-epidemiological SA framework to other diseases, deeper exploration of various immunological parameters, and refinement of within-host models for enhanced predictive power.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Epidemiology</span>
                    
                    <span class="tag">Infectious Diseases</span>
                    
                    <span class="tag">Immunology</span>
                    
                    <span class="tag">Virology</span>
                    
                    <span class="tag">Public Health</span>
                    
                    <span class="tag">Mathematical Biology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Sensitivity Analysis</span>
                    
                    <span class="tag tag-keyword">Immuno-Epidemiological Models</span>
                    
                    <span class="tag tag-keyword">Vector-Host Model</span>
                    
                    <span class="tag tag-keyword">Within-Host Dynamics</span>
                    
                    <span class="tag tag-keyword">Population Dynamics</span>
                    
                    <span class="tag tag-keyword">Basic Reproduction Number (R0)</span>
                    
                    <span class="tag tag-keyword">Rift Valley Fever Disease</span>
                    
                    <span class="tag tag-keyword">Disease Control Strategies</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Sensitivity Analysis (SA) is a useful tool to measure the impact of changes in model parameters on the infection dynamics, particularly to quantify the expected efficacy of disease control strategies. SA has only been applied to epidemic models at the population level, ignoring the effect of within-host virus-with-immune-system interactions on the disease spread. Connecting the scales from individual to population can help inform drug and vaccine development. Thus the value of understanding the impact of immunological parameters on epidemiological quantities. Here we consider an age-since-infection structured vector-host model, in which epidemiological parameters are formulated as functions of within-host virus and antibody densities, governed by an ODE system. We then use SA for these immuno-epidemiological models to investigate the impact of immunological parameters on population-level disease dynamics such as basic reproduction number, final size of the epidemic or the infectiousness at different phases of an outbreak. As a case study, we consider Rift Valley Fever Disease (RFVD) utilizing parameter estimations from prior studies. SA indicates that 1% increase in within-host pathogen growth rate can lead up to 8% increase in R0; up to 1% increase in steady-state infected host abundance, and up to 4% increase in infectiousness of hosts when the reproduction number R0 is larger than one. These significant increases in population-scale disease quantities suggest that control strategies that reduce the within-host pathogen growth can be important in reducing disease prevalence.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>